A Case Study in Osteoporosis
Jaquel Patterson, ND Tolle Causam The Osteoinductive Activity of Cyplexinol Osteoporosis, which is one of the most common metabolic bone diseases, is characterized by the loss of bone mass and […]
Jaquel Patterson, ND Tolle Causam The Osteoinductive Activity of Cyplexinol Osteoporosis, which is one of the most common metabolic bone diseases, is characterized by the loss of bone mass and […]
Jeremy Appleton, ND Vis Medicatrix Naturae The body of probiotic research continues to expand and diversify, and is accompanied by an expanded understanding of microbiome-host interactions and a broadening array
Sunita Iyer, ND, LM Tolle Totum I have both the privilege and challenge of working with families in the preconception, perinatal, and postpartum stages of parenting. This means that I
Dr. Jennifer Bunzenmeyer, ND Hormonal Cacophony: a Bloody Menses Often, when I ask my clients if they have PMS, they jokingly respond, “you should ask my husband!” It is well accepted
Kaitlyn Zorn, HBSc, ND Vis Medicatrix Naturae “Estrogen dominance” is a term used in naturopathic medicine to describe a high ratio of estrogen to progesterone. Different factors in our Western
Thara Vayali, ND Tolle Totum Heavy menstrual bleeding (HMB) is 1 of the most common presenting concerns in gynecology.1 Some studies have reported that 30% of menstruating women experience HMB,2,3
Naturopathic Perspective Keri Layton, ND The conversation about the role of women in the workplace has reached fever pitch in recent years. Sheryl Sandberg’s 2013 book and directive Lean In1
Tolle Totum Artemis Morris, ND, MS, LAc Infertility, defined as the inability to conceive after 1 year of unprotected sex, is a growing problem affecting 1 million married premenopausal women,
Vis Medicatrix Naturae Kate Naumes, ND Carina Parikh, MSN, MSiMR David Daniels Infertility affects as many as 12.3% of women ages 15-44 (or 7.5 million women) in the United States.1
Tolle Causam Andrea Purcell, NMD Alopecia that occurs in menopause is really a type of late-onset Female-Pattern Hair Loss (FPHL), which occurs in approximately 50% of women by the age